Member Exclusive NEWS ROUND-UP

Cell therapy weekly: Big pharma pass off gene therapy portfolios to smaller developers

This week: Pfizer and GSK hand off CAR-T and gene therapy programs, Novartis acquires gene therapy developer

Go to the profile of RegMedNet
Apr 12, 2018
1
0

Please sign in or register for FREE

Register to RegMedNet

RegMedNet is a free content and networking hub promoting global connection, knowledge-sharing and collaboration between all members of the regenerative medicine field.

Register

No comments yet.